About Intersect Diagnostics
Intersect Diagnostics is a Healthcare company based in Whitehall Township (United States) founded in 2019 by Boaz Kurtis. Biomarkers for precision therapeutics in tumor receptor detection are developed. Its chief executive, as recorded, is Boaz Kurtis. Its focus areas include Life Sciences, Genomics, Genomics Research and Biomarker Discovery. Its legal entity is Intersect Diagnostics Inc. Similar companies include Metabolon, Maze Therapeutics and Alector; 3 of its 3 listed similar companies have raised funding.
Company details
Intersect Diagnostics was founded in 2019 in Whitehall Township, United States, within the biotechnology sector. Biomarkers are developed to support precision therapeutics. Image and processing test results are delivered to partners, with images digitized for tumor receptor expression detection. Secure data transfer specifications are utilized to ensure compliance and data integrity in operations.
- Headquarters Whitehall Township, United States
- Founders Boaz Kurtis
- SectorsHealthcare
- Email••••••••
- Website intersectdx.com
- Social LinkedIn
- Legal Name Intersect Diagnostics Inc.
- Latest Funding Round$75K (USD), Debt – Conventional
Mar 2019
Funding Insights of Intersect Diagnostics
- Total Rounds 1
- Last Round Debt – Conventional — $75,000
- First Round $75,000
(Mar 2019)
All 1 funding rounds of Intersect Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2019 | $75,000 | Debt – Conventional | – | – | – |
People of Intersect Diagnostics
7 people are tracked at Intersect Diagnostics (3 in leadership, 3 in board & advisors, 1 in team).
| Name | Role | Group |
|---|---|---|
Boaz Kurtis | Founder & CEO | Leadership |
Mijanou Van Der Woude | VP, Operations | Leadership |
Kyle Fox | Head of Corporate Development | Leadership |
Jared Burks | Chief Scientific Advisor | Board & advisors |
Mohan Singh | Scientific Advisor | Board & advisors |
Paul Boutros | Scientific Advisor | Board & advisors |
Jed Weiner | Outside General Counsel | Team |
Complete people profiles for Intersect Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Intersect Diagnostics
2 dated milestones of Intersect Diagnostics, from founding to its latest funding, stage changes and deals.
- Founded Intersect Diagnostics is founded.
- Funding First funding round of $75K.
Similar companies to Intersect Diagnostics
Intersect Diagnostics has 3 listed similar companies in our database, 3 of them funded. They include Metabolon, Maze Therapeutics and Alector.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| metabolon.com | 2000 | Morrisville, United States | $165.87M | 189 | Solutions for biomarker discovery and diagnostic testing are provided. | |
| mazetx.com | 2018 | Redwood, United States | $496M | 111 | Genetic biomarkers are developed for neurological, metabolic, and renal diseases. | |
| alector.com | 2013 | San Francisco, United States | $214.78M | 211 | Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. |
Detailed similar companies of Intersect Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Intersect Diagnostics (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Intersect Diagnostics
Intersect Diagnostics was founded in 2019.
Intersect Diagnostics is headquartered in Whitehall Township, United States. It is registered at Whitehall Township, Pennsylvania, United States.
Boaz Kurtis is the CEO of Intersect Diagnostics, as recorded in our data. They have also founded this company.
Intersect Diagnostics was founded in 2019 in Whitehall Township, United States, within the biotechnology sector. Biomarkers are developed to support precision therapeutics. Image and processing test results are delivered to partners, with images digitized for tumor receptor expression detection. Secure data transfer specifications are utilized to ensure compliance and data integrity in operations.
Intersect Diagnostics's top competitors include Alector, Maze Therapeutics and Metabolon.
Intersect Diagnostics operates through Intersect Diagnostics Inc..